Tilli
The Aussie trial was approved - but never started as they decided to take on a US centric and bigger trial.
Better for credibility, and I suspect indirectly financially as in the USA. I have never seen it written, as I dont know the trial format (? not sure if it is double blind placebo controlled) - but there is a way you can charge patients in the USA for the Oncosil product once you have the IDE approved. They expect IDE approval in Q4 2015.
As Oncosil is a "device" - you need less data than for a drug submission for CE and IDE.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.000(0.00%) |
Mkt cap ! $21.64M | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.15 | $1.14 | $19.71K | 17.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 5171 | 1 |
View Market Depth
| Last trade - 10.59am 29/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |